P

Inventor

COOK PHILLIP DAN

US164 patents
⚠️ This page may combine multiple inventors who share the name “COOK PHILLIP DAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ISIS PHARMACEUTICALS INC

47 patents
USRE39464EJan 9, 2007

Oligonucleolotides having site specific chiral phosphorothioate internucleoside linkages

ISIS PHARMACEUTICALS INC235 citations99
US7105499B2Sep 12, 2006

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

ISIS PHARMACEUTICALS INC233 citations99
US7037646B1May 2, 2006

Amine-derivatized nucleosides and oligonucleosides

ISIS PHARMACEUTICALS INC197 citations99
US7015315B1Mar 21, 2006

Gapped oligonucleotides

ISIS PHARMACEUTICALS INC409 citations99
US6900297B1May 31, 2005

Amine-derivatized nucleosides and oligonucleosides

ISIS PHARMACEUTICALS INC187 citations99
US6783931B1Aug 31, 2004

Amine-derivatized nucleosides and oligonucleosides

ISIS PHARMACEUTICALS INC194 citations99
US6639062B2Oct 28, 2003

Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefrom

ISIS PHARMACEUTICALS INC259 citations99
US6600032B1Jul 29, 2003

2′-O-aminoethyloxyethyl-modified oligonucleotides

ISIS PHARMACEUTICALS INC338 citations99
US6534639B1Mar 18, 2003

Guanidinium functionalized oligonucleotides and method/synthesis

ISIS PHARMACEUTICALS INC261 citations99
US6528631B1Mar 4, 2003

Oligonucleotide-folate conjugates

ISIS PHARMACEUTICALS INC461 citations99
US6451991B1Sep 17, 2002

Sugar-modified gapped oligonucleotides

ISIS PHARMACEUTICALS INC244 citations99
US6399754B1Jun 4, 2002

Sugar modified oligonucleotides

ISIS PHARMACEUTICALS INC121 citations99
US6395492B1May 28, 2002

Derivatized oligonucleotides having improved uptake and other properties

ISIS PHARMACEUTICALS INC234 citations99
US6335434B1Jan 1, 2002

Nucleosidic and non-nucleosidic folate conjugates

ISIS PHARMACEUTICALS INC558 citations99
US6326199B1Dec 4, 2001

Gapped 2′ modified oligonucleotides

ISIS PHARMACEUTICALS INC282 citations99
US6277603B1Aug 21, 2001

PNA-DNA-PNA chimeric macromolecules

ISIS PHARMACEUTICALS INC216 citations99
US6242589B1Jun 5, 2001

Phosphorothioate oligonucleotides having modified internucleoside linkages

ISIS PHARMACEUTICALS INC171 citations99
US6239265B1May 29, 2001

Oligonucleotides having chiral phosphorus linkages

ISIS PHARMACEUTICALS INC471 citations99
US6172209B1Jan 9, 2001

Aminooxy-modified oligonucleotides and methods for making same

ISIS PHARMACEUTICALS INC378 citations99
US6166199ADec 26, 2000

N-2 substituted purines

ISIS PHARMACEUTICALS INC157 citations99
US6153737ANov 28, 2000

Derivatized oligonucleotides having improved uptake and other properties

ISIS PHARMACEUTICALS INC460 citations99
US6127533AOct 3, 2000

2'-O-aminooxy-modified oligonucleotides

ISIS PHARMACEUTICALS INC227 citations99
US5914396AJun 22, 1999

2'-O-modified nucleosides and phosphoramidites

ISIS PHARMACEUTICALS INC169 citations99
US5808027ASep 15, 1998

N-2 substituted purines in oligonucleotides

ISIS PHARMACEUTICALS INC171 citations99
US5777092AJul 7, 1998

Heteroatomic oligonucleoside linkages

ISIS PHARMACEUTICALS INC128 citations99
US5700922ADec 23, 1997

PNA-DNA-PNA chimeric macromolecules

ISIS PHARMACEUTICALS INC810 citations99
US5688941ANov 18, 1997

Methods of making conjugated 4' desmethyl nucleoside analog compounds

ISIS PHARMACEUTICALS INC804 citations99
US5681941AOct 28, 1997

Substituted purines and oligonucleotide cross-linking

ISIS PHARMACEUTICALS INC1,392 citations99
US5677437AOct 14, 1997

Heteroatomic oligonucleoside linkages

ISIS PHARMACEUTICALS INC1,250 citations99
US5661134AAug 26, 1997

Oligonucleotides for modulating Ha-ras or Ki-ras having phosphorothioate linkages of high chiral purity

ISIS PHARMACEUTICALS INC249 citations99
US5623070AApr 22, 1997

Heteroatomic oligonucleoside linkages

ISIS PHARMACEUTICALS INC1,420 citations99
US5608046AMar 4, 1997

Conjugated 4'-desmethyl nucleoside analog compounds

ISIS PHARMACEUTICALS INC1,669 citations99
US5576208ANov 19, 1996

Antisense oligonucleotide inhibition of the RAS gene

ISIS PHARMACEUTICALS INC151 citations99
US5489677AFeb 6, 1996

Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms

ISIS PHARMACEUTICALS INC1,836 citations99
US5386023AJan 31, 1995

Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling

ISIS PHARMACEUTICALS INC1,009 citations99
US5378825AJan 3, 1995

Backbone modified oligonucleotide analogs

ISIS PHARMACEUTICALS INC1,016 citations99
US5223618AJun 29, 1993

4'-desmethyl nucleoside analog compounds

ISIS PHARMACEUTICALS INC578 citations99
US5218105AJun 8, 1993

Polyamine conjugated oligonucleotides

ISIS PHARMACEUTICALS INC1,173 citations99
US5138045AAug 11, 1992

Polyamine conjugated oligonucleotides

ISIS PHARMACEUTICALS INC1,414 citations99
US7202224B2Apr 10, 2007

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

ISIS PHARMACEUTICALS INC222 citations98
US7101993B1Sep 5, 2006

Oligonucleotides containing 2′-O-modified purines

ISIS PHARMACEUTICALS INC159 citations98
US6861514B2Mar 1, 2005

Nucleosidic and non-nucleosidic folate conjugates

ISIS PHARMACEUTICALS INC122 citations98
US6753423B1Jun 22, 2004

Compositions and methods for enhanced biostability and altered biodistribution of oligonucleotides in mammals

ISIS PHARMACEUTICALS INC88 citations98
US6747014B2Jun 8, 2004

Compositions and methods for non-parenteral delivery of oligonucleotides

ISIS PHARMACEUTICALS INC356 citations98
US6531584B1Mar 11, 2003

2'modified oligonucleotides

ISIS PHARMACEUTICALS INC407 citations98
US6440943B1Aug 27, 2002

Oligonucleotides having site specific chiral phosphorothioate internucleoside linkages

ISIS PHARMACEUTICALS INC80 citations98
US6222025B1Apr 24, 2001

Process for the synthesis of 2′-O-substituted pyrimidines and oligomeric compounds therefrom

ISIS PHARMACEUTICALS INC342 citations98

MERCK & CO INC

3 patents

Showing the top 50 of 164 patents by PatentIndex Score.